Process for producing drug ultramicroparticle and apparatus therefor

Details for Australian Patent Application No. 2004263040 (hide)

Owner Eisai R&D Management Co., Ltd.

Inventors Onai, Katsumi; Yamaguchi, Takehiro; Kato, Akira; Nomura, Teruko

Agent Davies Collison Cave

Pub. Number AU-B-2004263040

PCT Pub. Number WO2005/013938

Priority 2003-287943 06.08.03 JP

Filing date 4 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

B01F 5/10 (2006.01) Mixers

B01F 17/14 (2006.01) Use of substances as emulsifying, wetting, dispersing, or foam-producing agents - Derivatives of phosphoric acid

B01F 17/42 (2006.01) Use of substances as emulsifying, wetting, dispersing, or foam-producing agents - Ethers, e.g. polyglycol ethers of alcohols or phenols

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013938 Priority application(s): WO2005/013938

7 June 2007 Assignment before Grant

  Eisai Co., Ltd. The application has been assigned to Eisai R&D Management Co., Ltd.

11 March 2010 Application Accepted

  Published as AU-B-2004263040

8 July 2010 Standard Patent Sealed

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263054-Preparing method for controlled released type tablet tamsulosin HCl and the tablet thereof

2004263039-Aerosol for controlling insect pests